Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Clinics and Research in Hepatology and Gastroenterology|May 10, 2016
Advances in management of adjuvant chemotherapy in rectal cancer: Consequences for clinical practiceJeanne Netter, Richard Douard, Catherine Durdux, et al.Cancer Treatment Reviews|September 5, 2024
Early-Onset colorectal Cancer: From the laboratory to the clinicAnnalice Gandini, Julien Taieb, Hélène Blons, et al.Bulletin Du Cancer|December 12, 2018
[Lynch syndrome: What is new?]Anna Pellat, Jeanne Netter, Géraldine Perkins, et al.European Journal of Human Genetics : EJHG|March 18, 2025
Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotypeAntoine Dardenne, Marion Dhooge, Noémie Basset, et al.The Oncologist|June 4, 2026
Hepatic Arterial Infusion Chemotherapy for Metastatic Colorectal Cancer: Real-World Outcomes of Intensification and Salvage StrategiesAnnalice Gandini, Federico Lipsich, Jeanne Netter-Coti, et al.Proceedings of the National Academy of Sciences of the United States of America|March 23, 2013
Enterocyte loss of polarity and gut wound healing rely upon the F-actin-severing function of villinFlorent Ubelmann, Mathias Chamaillard, Fatima El-Marjou, et al.British Journal of Cancer|July 21, 2018
Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with menSimon Pernot, Pauline Boucheron, Hélène Péré, et al.Bulletin Du Cancer|January 23, 2015
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancerJeanne Netter, Jacqueline Lehmann-Che, Jerome Lambert, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 6, 2018
Clinical implications of CTNNA1 germline mutations in asymptomatic carriersPatrick R Benusiglio, Chrystelle Colas, Erell Guillerm, et al.European Journal of Human Genetics : EJHG|May 13, 2026
Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF networkMaxime Rémond, Youenn Drouet, Antoine Dardenne, et al.Pageof 2